OriGene Antibodies in recent publications
Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas Blood, Mar 2013; 121: 2563 - 2566.
Regulation of the PI3-K/Akt Survival Pathway in the Rat Endometrium Biol Reprod, Mar 2013; 88: 79.
RNA elements directing in vivo assembly of the 7SK/MePCE/Larp7 transcriptional regulatory snRNP Nucleic Acids Res., Mar 2013; 10.1093/nar/gkt159.
Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements Haematologica, Mar 2013; 98: 404 - 408.
View All Citations >>
Home All anti-CD80 antibodies
Anti-CD80 Antibody EP1155Y
Also for CD80 (NM_005191)
Homo sapiens CD80 molecule (CD80)
B7; B7-1; B7.1; BB1; CD28LG; CD28LG1; LAB7
A synthetic peptide corresponding to residues of human B7-1 was used an immunogen.
50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% BSA.
Human, Mouse, Rat
WB: 1:20,000 50,000; IHC: 1:100 250; ICC: 1:100 250; FC: 1:20
The B-lymphocyte activation antigen B7-1 (formerly referred to as B7) provides regulatory signals for T lymphocytes as a consequence of binding to the CD28 (MIM 186760) and CTLA4 (MIM 123890) ligands of T cells.[supplied by OMIM].
Toll-like receptor signaling pathway
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot analysis on THP-1 cell lysate using anti-B7-1 RabMAb (TA303430), dilution 1:50,000
Immunohistochemical staining of paraffin-embedded human tonsils using anti-B7-1 RabMAb (TA303430).